Biossimilar study at ESMO 2017

It´s happening in Madri, Spain, ESMO 2017 one of the most important oncological event promoted by the Europeen Society for Medical oncology. 

With 16.000 members thar represents professionals from more then 130 countries, ESMO is a professional organization. 

Dr. Gilberto Amorim, member from Scientific Board from Fundação Laço Rosa, was at the conference. 

" The European Medicines Agency will discuss its plan for healthcare professionals, and a clinician will talk about how to build confidence to prescribe biosimilars. The crucial role of specialist nurses will be highlighted, and a patient will provide a perspective on what has been learned and what can be improved. The potential for biosimilars to improve the financial sustainability of healthcare systems will also be discussed. Read the ESMO position paper on biosimilars" 

Read more here: 

http://www.esmo.org/Conferences/ESMO-2017-Congress/Press-Media/Press-Releases/Incoming-Wave-Biosimilars-Oncology-Special-Session-ESMO-2017